Barland et al., 2004 - Google Patents
Imiquimod-induced interleukin-1α stimulation improves barrier homeostasis in aged murine epidermisBarland et al., 2004
View HTML- Document ID
- 12198979186621266792
- Author
- Barland C
- Zettersten E
- Brown B
- Ye J
- Elias P
- Ghadially R
- Publication year
- Publication venue
- Journal of investigative dermatology
External Links
Snippet
In response to acute disruption of the permeability barrier of aged mammals there is a diminished capacity for barrier recovery, analogous to other aged organs when stressed. Acute barrier disruption increases levels of epidermal cytokines, and cytokines are known …
- 102000004125 Interleukin-1alpha 0 title abstract description 80
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/19—Cytokines; Lymphokines; Interferons
- A61K38/21—Interferons [IFN]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic, hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/127—Liposomes
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K8/00—Cosmetic or similar toilet preparations
- A61K8/18—Cosmetic or similar toilet preparations characterised by the composition
- A61K8/30—Cosmetic or similar toilet preparations characterised by the composition containing organic compounds
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Barland et al. | Imiquimod-induced interleukin-1α stimulation improves barrier homeostasis in aged murine epidermis | |
Oikarinen et al. | A new method to measure type I and III collagen synthesis in human skin in vivo: demonstration of decreased collagen synthesis after topical glucocorticoid treatment | |
Grether-Beck et al. | Urea uptake enhances barrier function and antimicrobial defense in humans by regulating epidermal gene expression | |
Choi et al. | Role of ceramides in barrier function of healthy and diseased skin | |
Wood et al. | Barrier disruption stimulates interleukin-1α expression and release from a pre-formed pool in murine epidermis | |
Elias et al. | Stratum corneum lipids in disorders of cornification. Steroid sulfatase and cholesterol sulfate in normal desquamation and the pathogenesis of recessive X-linked ichthyosis. | |
Jensen et al. | Roles for tumor necrosis factor receptor p55 and sphingomyelinase in repairing the cutaneous permeability barrier | |
Elias et al. | Skin barrier | |
Kovanen et al. | Regulation of low density lipoprotein receptors by adrenocorticotropin in the adrenal gland of mice and rats in vivo. | |
US6010691A (en) | Methods for enhancing permeation of a topically administered physiologically active substance | |
Mansbridge et al. | Role of transforming growth factor beta in the maturation of human epidermal keratinocytes | |
JP2003137807A (en) | Collagen production promoter, cosmetics, food and medicine containing the same, and external preparation for prevention or improvement of skin diseases | |
CA2076699A1 (en) | Compositions for topical treatment of psoriasis and atopic dermatitis | |
Hardardóttir et al. | LPS and cytokines regulate extra hepatic mRNA levels of apolipoproteins during the acute phase response in Syrian hamsters | |
IL109037A (en) | Compositions for inducing phase separation of epithelial lipid bilayers and preparation of said compositions | |
Linck et al. | Long-term beta adrenoceptor-mediated alteration in contractility and expression of phospholamban and sarcoplasmic reticulum Ca++-ATPase in mammalian ventricle | |
Alessandrini et al. | Alterations of glucosylceramide-β-glucosidase levels in the skin of patients with psoriasis vulgaris | |
Kostner et al. | Lipoprotein (a) mediates high affinity low density lipoprotein association to receptor negative fibroblasts. | |
US7528168B2 (en) | Inhibitors of the fatty acid oxidation for the prophylaxis and/or the treatment of chronic and/or atopic skin diseases | |
Jonca | Ceramides metabolism and impaired epidermal barrier in cutaneous diseases and skin aging: focus on the role of the enzyme PNPLA1 in the synthesis of ω-O-acylceramides and its pathophysiological involvement in some forms of congenital ichthyoses | |
WO1994021271A1 (en) | Methods and compositions for inducing phase separation of epithelial lipid bilayers | |
Leonardi et al. | Effect of fenoxycarb on leucine uptake and lipid composition of midgut brush border membrane in the silkworm, Bombyx mori (Lepidoptera, Bombycidae) | |
Alessandrini et al. | Permeability barrier disruption increases the level of serine palmitoyltransferase in human epidermis | |
Bui et al. | Zinc Status and Interleukin-1β-Induced Alterations in Mineral Metabolism in Rats | |
US6869603B2 (en) | Lipoprotein lipase and lipoprotein lipase activators in the treatment of inflammatory conditions |